Hepatitis C

Increase access to hepatitis C (HCV) testing and care in drug services- a toolkit

Created by
EMCDDA

People who inject drugs (PWID) are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains low among people who inject drugs and effective approaches to promote testing as the first element of a cascade of care are particularly needed.

Manual: increasing access to hepatitis C testing and care for people who inject drugs

Created by
EMCDDA
Publication Date
This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment for people who use drugs.

Eliminating hepatitis C in prisons: Lessons from the SToP-C study

Online,

Eliminating hepatitis C in prisons will be a crucial setting if World Health Organization (WHO) elimination targets are to be achieved. For World Hepatitis Day, we’ll hear from experts about the evidence that treatment as prevention in prisons works, and how it can be rolled out in Australia to have the most effective impact.

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients

Citation
Fuster D, Nunes D, Cheng DM, Saitz R, Samet JH. Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients. Viruses. 2021; 13(5):716. https://doi.org/10.3390/v13050716
Publication Date

Abstract

Background: The impact of Hepatitis C virus (HCV) RNA levels on the evolution of chronic HCV infection-related liver damage is controversial. Heavy alcohol use is believed to have a deleterious impact on the course of HCV disease, but current knowledge about the possible effect of alcohol use on HCV RNA levels in HIV/HCV coinfected patients is limited.

Your Guide to Integrating HCV Services into Opioid Treatment Programs - ATTC Network

Created by
Addiction Technology Transfer Center Network Coordinating Office
Publication Date

The opioid epidemic has resulted in significant increases in Hepatitis C Virus (HCV) among people who inject drugs, accounting for 23% of new infections. HCV is completely curable and testing and treatment are the path to cure. Opioid Treatment Providers (OTPs) play a critical role in comprehensive approaches to addressing HCV and this guide is one tool to help.

World Hepatitis Day 2020

World Hepatitis Day is commemorated each year on 28 July to enhance awareness of viral hepatitis, an inflammation of the liver that causes a range of health problems, including liver cancer. There are five main strains of the hepatitis virus – A, B, C, D and E. Together, hepatitis B and C are the most common cause of deaths, with 1.3 million lives lost each year. Amid the COVID-19 pandemic, viral hepatitis continues to claim

Dual Pandemics – What Will COVID-19 Mean for Hepatitis C Elimination?

Webinar,

Australia is a world leader in its efforts to eliminate hepatitis C and to improve the health of people who use drugs. But COVID-19, on a backdrop of economic uncertainty, anxiety and unemployment has the potential to disrupt our support, prevention and cure efforts – especially given the populations most impacted by hepatitis C and drug dependence are some of our most vulnerable Australians. 

9th International Conference on Hepatitis Care in Substance Users

Glasgow, United Kingdom,

The 9th International Conference on Hepatitis Care in Substance Users will be held in Glasgow, Scotland, 8 – 10 October 2020.

The INHSU annual conference is a unique opportunity to connect with the global community working to improve health outcomes for people who use drugs including the prevention, treatment and care of hepatitis C.

National Conference: Hepatitis C Case-finding in Addiction Related Services

Stirling, United Kingdom,

This FREE one day conference, organised by Hepatitis Scotland, is aimed at staff who work in, or have strategic responsibility for, primary and secondary care addiction services.

The day will explore the background to developing successful hepatitis C case-finding initiatives, demonstrating real world successes and issues for practitioners to consider.